The Aducanumab Controversy: Accelerated FDA Approval Leads to Agency Distrust
… cardiovascular disease. Scientists have validated LDL as a marker of heart disease and justified the use of lipid-lowering drugs due to their …
… cardiovascular disease. Scientists have validated LDL as a marker of heart disease and justified the use of lipid-lowering drugs due to their …